ENGAGE-TB Operational Guidance | November 1, 2013
1 |
ENGAGE-TB
Operational Guidance
Paris, 1 November 2013
ENGAGE-TB Operational Guidance Paris, 1 November 2013 1 | ENGAGE-TB - - PowerPoint PPT Presentation
ENGAGE-TB Operational Guidance Paris, 1 November 2013 1 | ENGAGE-TB Operational Guidance | November 1, 2013 Outline Background Purpose Target audience Integrating TB activities The ENGAGE-TB approach 2 | ENGAGE-TB Operational
ENGAGE-TB Operational Guidance | November 1, 2013
1 |
Paris, 1 November 2013
ENGAGE-TB Operational Guidance | November 1, 2013
2 |
ENGAGE-TB Operational Guidance | November 1, 2013
3 |
ENGAGE-TB Operational Guidance | November 1, 2013
4 |
TB second largest killer after HIV; but is curable A third of those with TB are either not diagnosed or not reported MDR-TB growing; requires longer treatment and adherence A wider range of stakeholders needs to be involved NGOs and other CSOs are able to reach remote and marginalized populations Community-based TB activities can help to reach many more
67% 33%
Persons with TB
Reached/reported Unreached/not reported
ENGAGE-TB Operational Guidance | November 1, 2013
5 |
TB linked to HIV infection, malnutrition, alcohol, drug and tobacco use, diabetes
10 million “TB”
Migrants, prisoners, minorities, refugees face risks, discrimination & barriers to care People living in crowded & poorly ventilated settings
ENGAGE-TB Operational Guidance | November 1, 2013
6 |
Risk Normal TB
Neonatal effects (per 1000 pregnancies) Low birth weight (< 2.5Kg) 165 342 Prematurity (< 37wk) 111 228 Small for dates 79 202 Perinatal death 16 101 Fetal death (16-28wk) 2.3 20.1 Maternal effects Pre-eclampsia 47 74 Vaginal bleeding 22 44
Bj er erked edal 1975 1975;Jan ana a 1994 1994;Bot ha ham ley y 2001 2001;Kha han n 2001 2001; Figueroa-Dam am ian an R,1998 1998
ENGAGE-TB Operational Guidance | November 1, 2013
7 |
ENGAGE-TB approach
ENGAGE-TB Operational Guidance | November 1, 2013
8 |
ENGAGE-TB Operational Guidance | November 1, 2013
9 |
ENGAGE-TB Operational Guidance | November 1, 2013
10 |
– Raise awareness – Encourage those with symptoms to get their sputum examined – Provide support eg nutritional, psychosocial, treatment adherence, transport
ENGAGE-TB Operational Guidance | November 1, 2013
11 |
ENGAGE-TB Operational Guidance | November 1, 2013
12 |
ENGAGE-TB Operational Guidance | November 1, 2013
13 |
ENGAGE-TB Operational Guidance | November 1, 2013
14 |
ENGAGE-TB Operational Guidance | November 1, 2013
15 |
ENGAGE-TB Operational Guidance | November 1, 2013
16 |
ENGAGE-TB Operational Guidance | November 1, 2013
17 |
ENGAGE-TB Operational Guidance | November 1, 2013
18 |
ENGAGE-TB Operational Guidance | November 1, 2013
19 |
– Referrals and new notifications: how many referred by CHWs and CHVs – Treatment success rates among those receiving support from CHWs and CHVs
– Presence of an NCB, trends in membership, etc – Quality of NTP interaction with NCB
ENGAGE-TB Operational Guidance | November 1, 2013
20 |
Country Notified patients from referrals Patients who received treatment support (2011 cohort)
%age
Source of data
%age
Source of data Burkina Faso
9%
All districts
33%
All districts Côte d'Ivoire
16%
59/82 districts N/A Democratic Republic
10%
45/515 districts
3%
8/515 districts Ethiopia
33%
98/821 districts
40%*
98/821 districts India
3%
374/662 districts
50%
All districts Kenya
5%
All districts
88%
All districts Malawi
20%
2/28 districts
91%
2/28 districts Myanmar
2%
92/330 districts
2%
92/330 districts Nigeria N/A
5%
36 districts Rwanda
28%
All districts
46%
All districts Senegal
6%
All districts N/A Tanzania
14%
63/162 districts
86%
All districts Uganda
N/A 35%
All districts Community contributions to TB case notifications and treatment adherence support, 2012
ENGAGE-TB Operational Guidance | November 1, 2013
21 |
Indicator 1: Referrals and new notifications
Definition Number of new TB patients (all forms) diagnosed and notified with TB who were referred by community health workers and community volunteers expressed as a percentage of all new TB patients notified in the basic management unit (BMU) during a specified period Numerator Number of new TB patients (all forms) referred by community health workers or community volunteers to a health facility for diagnosis and notified in the BMU(s) in a specified period Denominator Number of new TB patients (all forms) notified in the BMU(s) in the same period Purpose To measure the level of engagement of community health workers and community volunteers in increasing new notifications of TB. It can also indicate the effectiveness of the referral system in ensuring the flow of persons with presumptive TB from community-based structures to the BMU. Method Entries on tuberculosis treatment cards, the presumptive TB register (also known as ‘TB suspects’ register) kept at facilities, the BMU TB register and the laboratory register should be modified to include ‘Referral by community health workers and community volunteers’, to allow standardized recording of the community contribution to referral. The quarterly report on TB registration in the BMU should also be adjusted to record this contribution.
ENGAGE-TB Operational Guidance | November 1, 2013
22 |
Indicator 2: Treatment success
Definition New TB patients (all forms) successfully treated (cured plus completed treatment) who received support for treatment adherence from community health workers or community volunteers among all new TB patients (all forms) provided with treatment adherence support by community health workers or community volunteers (number and percentage) Numerator Number of new TB patients (all forms) successfully treated and provided with treatment adherence support by community health workers or community volunteers in the BMU(s) in a specified period Denominator Total number of new TB patients (all forms) given treatment adherence support by community health workers or community volunteers in the same period Purpose To measure the scope and quality of implementation of community-based TB activities particularly relating to treatment outcome of patients. It can also indicate the acceptability of community health workers or community volunteers to patients with TB as treatment adherence support providers. Method Treatment adherence includes all efforts and services provided by community health workers and volunteers to TB patients receiving treatment to help them complete their treatment
ENGAGE-TB Operational Guidance | November 1, 2013
23 |
Purpose Periodic evaluation provides a qualitative view of the progress of community-based TB activities. In particular, it helps to assess the contributions of NGOs and other CSOs to new case notifications and to treatment outcomes. It also indicates whether NGO contributions are increasing or decreasing and reflects the quality of the relations between NTPs and NGOs on the basis of variables such as the frequency of meetings, the quality of such meetings, the cooperation of people involved, the factors in success and the overall interest and drive of the NTP in involving NGOs and other CSOs in TB activities. Indicators
*trends in membership *frequency of meeting *spread to subnational levels *coordination between levels *mechanisms for transferring knowledge, skills and resources
*frequency of meetings *quality of follow-up on agreed actions *availability of TB diagnostic services and drugs
notifications and treatment success, with trends in these variables over time
successes and new opportunities
Annex 2. Periodic evaluation
ENGAGE-TB Operational Guidance | November 1, 2013
24 |